Benzinga | Mar 9, 2021 09:15AM EST

ANI Pharmaceuticals Q4 Adj. EPS $0.80 Misses $0.94 Estimate, Sales $57.30M Beat $54.27M Estimate

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $0.80 per share which missed the analyst consensus estimate of $0.94 by 14.89 percent. This is a 25.93 percent decrease over earnings of $1.08 per share from the same period last year. The company reported quarterly sales of $57.30 million which beat the analyst consensus estimate of $54.27 million by 5.58 percent. This is a 19.46 percent increase over sales of $47.97 million the same period last year.